Axsome Therapeutics (AXSM) Misses Q1 EPS by 3c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• 1-800-FLOWERS.Com (FLWS) Misses Q4 EPS by 10c, Misses on Revenue; Offers Guidance
• Casey's General Stores (CASY) PT Lowered to $720 at UBS on Peak Fuel Margin Concerns